Funding · Company
Pheast Therapeutics, Inc.
Redwood City, CASoftware & Technology
Pheast Therapeutics, Inc. of Redwood City, CA has disclosed $100M across 2 Form D offerings filed with the SEC between Apr 10, 2025 and Oct 16, 2025.
$100M
Total disclosed
2
Form D offerings
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$25M
Form D · Oct 16, 2025 ↗
Q4 2025
· target $40M
$75M
Form D · Apr 10, 2025 ↗
Q2 2025
· 1 amendment, first filed Oct 28, 2022
Filing details
HeadquartersRedwood City, CAIndustrySoftware & Technology (Other Technology)Incorporated2020SEC CIK0001943737Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →